Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
49.14
+0.79 (1.63%)
At close: Jul 26, 2024, 4:00 PM
48.18
-0.96 (-1.95%)
After-hours: Jul 26, 2024, 4:46 PM EDT
Belite Bio Employees
Belite Bio had 20 employees as of December 31, 2023. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,581,600
Market Cap
1.46B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20 | 4 | 25.00% |
Dec 31, 2022 | 16 | 4 | 33.33% |
Dec 31, 2021 | 12 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Tilray Brands | 1,600 |
Phreesia | 1,438 |
Vir Biotechnology | 587 |
InMode | 581 |
Arcus Biosciences | 577 |
Dynavax Technologies | 408 |
Nurix Therapeutics | 284 |
BLTE News
- 6 weeks ago - Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan - GlobeNewsWire
- 2 months ago - Belite Bio to Participate in the Benchmark's 4th Annual Healthcare House Call Investor Conference - GlobeNewsWire
- 2 months ago - Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference - GlobeNewsWire
- 2 months ago - Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant - GlobeNewsWire
- 2 months ago - Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting - GlobeNewsWire
- 3 months ago - Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting - GlobeNewsWire